Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=26978558
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\26978558
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Womens+Health+(Lond)
2016 ; 12
(3
): 351-61
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Managing the female patient with hereditary angioedema
#MMPMID26978558
Banerji A
; Riedl M
Womens Health (Lond)
2016[Jun]; 12
(3
): 351-61
PMID26978558
show ga
Hereditary angioedema (HAE) is a rare disorder resulting from decreased
functional levels of C1-inhibitor (C1-INH), which manifests as periodic episodes
of localized edema which can be extremely painful, debilitating and even fatal if
the swelling affects the larynx. HAE can complicate many aspects of
obstetric/gynecologic care, and an awareness of the disease is critical for
clinicians involved in the care of women because of potential HAE-related
complications pertaining to pregnancy, labor and delivery, and other women's
health issues. This article provides a review of published literature specific to
HAE and its management in female patients, including important concerns regarding
obstetric/gynecologic care. A growing body of relevant experience is presented to
help guide the care of women with HAE.
|Angioedemas, Hereditary/*drug therapy/prevention & control
[MESH]
|Antifibrinolytic Agents/therapeutic use
[MESH]
|Complement C1 Inactivator Proteins/*therapeutic use
[MESH]